Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Radiomedix
AddedFeb 15, 2024
UpdatedJun 18, 2026
Radiomedix

Radiomedix

Series A

RadioMedix, a Houston-based biotech firm, innovates targeted radiopharmaceuticals for cancer diagnosis and therapy.

HQ
Houston, TX, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

RadioMedix, Inc., founded in Houston, Texas, is a clinical-stage biotechnology company dedicated to advancing the field of nuclear medicine. The company's core mission is to innovate targeted radiopharmaceuticals for the diagnosis, monitoring, and therapy of cancer. Their product portfolio includes PET imaging agents and therapeutic radiopharmaceuticals labeled with alpha and beta emitters. Additionally, RadioMedix offers CFR-compliant contract services for academic and industrial partners, aiming to enhance cancer treatment through precision medicine.

Notable figures associated with RadioMedix include its team of experienced scientists and industry experts who drive its research and development efforts. The company has made significant strides in the biotech sector, with key achievements including the development of novel radiopharmaceuticals that have progressed to clinical trials. RadioMedix's impact on the medical community is marked by its contributions to more effective cancer diagnostics and therapies, positioning it as a leader in the nuclear medicine landscape.

Radiomedix - Similar Companies

Radionetics Oncology logo

Radionetics Oncology

radionetics.com

Illumina Radiopharmaceuticals logo

Illumina Radiopharmaceuticals

RadioRx logo

RadioRx

radiorx.com

Nucleus RadioPharma logo

Nucleus RadioPharma

nucleusrad.com

Sabik Medical logo

Sabik Medical

Trevarx Biomedical logo

Trevarx Biomedical

trevarx.com

Radimmune Therapeutics logo

Radimmune Therapeutics

Mariana Oncology logo

Mariana Oncology

Radiology Partners logo

Radiology Partners

radpartners.com

NuView Life Sciences logo

NuView Life Sciences

XRad Therapeutics logo

XRad Therapeutics

Navidea Biopharmaceuticals logo

Navidea Biopharmaceuticals

navidea.com

Ratio Therapeutics logo

Ratio Therapeutics

ratiotx.com

Artbio logo

Artbio

artbio.com

NextImage Medical logo

NextImage Medical

Radiomedix - Quick Facts

Who are Radiomedix's competitors?

Companies similar to Radiomedix include Radionetics Oncology, Illumina Radiopharmaceuticals, RadioRx and Nucleus RadioPharma.

When was Radiomedix founded?

Radiomedix was founded in 2006.

Where is Radiomedix's headquarters located?

Radiomedix's headquarters is located in Houston, TX, US.

When was Radiomedix's last funding round?

Radiomedix's most recent funding round was for $40M (USD) in October 2022.

How much has Radiomedix raised to-date?

As of Oct 7, 2022, Radiomedix has raised a total of $40M (USD).

How many employees does Radiomedix have?

Radiomedix has 33 employees as of Feb 4, 2024.

Radiomedix - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Radiopharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified